Lessee, Operating Lease, Liability, to be Paid, Year One of Zivo Bioscience, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Zivo Bioscience, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Zivo Bioscience, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 30 Sep 2025 was $94,676, a 1923% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

Zivo Bioscience, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $94,676 +$89,995 +1923% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q4 2024 $3,000 21 Jan 2025 10-Q 15 May 2025 2025 Q1
Q3 2024 $4,681 -$24,808 -84% 13 Sep 2024 10-Q 15 May 2025 2025 Q1
Q3 2023 $29,489 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $58,776 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $88,063 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $116,933 31 Dec 2022 10-K 14 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.